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Purpose: Post-polypectomy bleeding is the most common colonoscopic polypec-
tomy complication. However, the risk of post-polypectomy bleeding in liver cir-
rhosis is unknown. We aimed to evaluate the risk of post-polypectomy bleeding in 
patients with liver cirrhosis. Materials and Methods: We included 89 patients 
with liver cirrhosis who received colonoscopic polypectomy between January 
2006 and October 2012. Three hundred forty-eight subjects without liver disease 
who underwent colonoscopic polypectomy comprised the control group. Risks of 
post-polypectomy bleeding were analyzed according to patient- and polyp-related 
factors. Results: Among 89 patients, 75 (84.3%) were Child-Pugh class A, 10 
(11.2%) were class B, and 4 (4.5%) were class C. Incidence of immediate post-
polypectomy bleeding was significantly increased in cirrhosis with Child-Pugh 
class B or C compared to liver cirrhosis with Child-Pugh class A or control group 
[hazard ratio (HR) 3.5; p<0.001]. Polyp size (HR 3.6; p=0.032) and pedunculated 
polyps (HR 2.4; p=0.022) were also significant risk factors for immediate post-
polypectomy bleeding in multivariate analysis. Conclusion: Cirrhotic patients 
with Child-Pugh class B or C have a high risk of immediate post-polypectomy 
bleeding. Thus, endoscopists should be cautious about performing colonoscopic 
polypectomy in patients with Child-Pugh class B or C.
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INTRODUCTION
Colorectal cancer is the third most common cancer worldwide and the second 
leading cause of cancer-related deaths.1,2 The role of colonoscopy has been empha-
sized as an effective tool for screening colorectal neoplasm.3-5 Particularly, colono-
scopic polypectomy can reduce the incidence and mortality of colorectal cancer by 
76--90%6,7 and 53%,8 respectively. Most colorectal polyps can be removed safely 
by various polypectomy techniques. However, serious complications, such as 
bleeding, perforation, and death can occur during the procedures. Among them, 
post-polypectomy bleeding (PPB) is one of the most common complications.9 
PPB can occur immediately following polypectomy or can be delayed up to 30 
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ypectomy and were reviewed retrospectively in the present 
study. The cirrhosis was diagnosed using clinical tools such 
as ultrasonography, computed tomography, magnetic reso-
nance imaging, transient elastography, liver biopsy, and se-
rum variables. The liver cirrhosis was stratified by Child-
Pugh class to show the disease severity.20 The exclusion 
criteria of the study were as follows: a final pathology diag-
nosis of a submucosal tumor including lipoma, carcinoid, 
and leiomyoma; removal of polyps by biopsy; a history of 
polypectomy (to avoid overlapping data); and a history of 
anticoagulant therapy. Finally, 89 patients with liver cirrho-
sis were included in the present study. The 348 healthy sub-
jects were selected as control group from the Severance 
Hospital colonoscopy cohort by using the propensity score 
for matching age, gender, and underlying disease during the 
same period (Fig. 1). All subjects of control group didn’t 
have abnormal finding in abdominal imaging evaluations 
and abnormal laboratory finding including viral markers.
We reviewed all of data including age, gender, body mass 
index (BMI), the use of antiplatelet therapy (aspirin and clop-
idogrel), underlying disease, bowel preparation, polyp mor-
phology, polyp size, polyp location, polyp histology, and the 
number of polypectomies. The bowel preparation was clas-
sified as inadequate or adequate.21 The polyp location was 
classified as the distal or proximal colon.11 The proximal co-
lon included the cecum, ascending colon, hepatic flexure, 
transverse colon and splenic flexure. The distal colon includ-
ed the descending colon, sigmoid colon and rectum. The pol-
yp histology was classified as neoplastic polyp or non-neo-
plastic polyp. A neoplastic polyp indicated tubular, villous, 
tubulovillous and serrated adenomas. A non-neoplastic polyp 
indicated an inflammatory or a hyperplastic polyp.
Colonoscopic polypectomy was performed by experi-
enced endoscopists. In most of cases with Child-Pugh class 
B or C cirrhosis, colonoscopy was performed due to abdom-
days. The rate of immediate PPB (IPPB) is reported to 
range from 2.1 to 9% depending on the study population 
and center type, and the delayed PPB (DPPB) incidence is 
0.7--2.5%.10-12 An age ≥65 years, cardiovascular or chronic 
renal disease, the use of anticoagulants, a polyp size greater 
than 10 mm, polyp morphology, poor bowel preparation, 
the cutting mode of electrosurgical current, and inadvertent 
cutting of a polyp before current application are noted as in-
dependent risk factors for IPPB.12 Advanced age, hyperten-
sion, large sessile polyps, polyps at the proximal colon and 
polypectomy with pure coagulation are known to be risk 
factors for DPPB.10,11,13 
Patients with liver cirrhosis have demonstrated greater 
risks for surgical- and anesthesia-related complications than 
those with a healthy liver.14-16 Thrombocytopenia occurs in 
76% of cirrhotic patients and it may increase the risk of 
bleeding during invasive procedures.17,18 Particularly, proce-
dure-related complications are associated with the severity 
of liver function. A previous study has reported mortality 
rates of 10, 17, and 63 percent in cirrhotic patients with 
Child-Pugh class A, B, and C undergoing abdominal surgery, 
respectively.19 However, the risk of PPB after colonoscopic 
polypectomy has not been well known in patients with liver 
cirrhosis. The aim of the present study was to evaluate the 
risk of PPB after colonoscopic polypectomy in patients with 
liver cirrhosis and compare it with those with a healthy liver.
MATERIALS AND METHODS
　　　
Patients and methods
From June 2006 to October 2012, 497 patients with liver cir-
rhosis underwent colonoscopy at Severance Hospital, Yonsei 
University College of Medicine, Seoul, Korea. Among them, 
106 cirrhotic patients (21.3%) received colonoscopic pol-
Fig. 1. Study design. IPPB, immediate post-polypectomy bleeding; DPPB, delayed post-polypectomy bleeding.
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cirrhotic patients with that in control patients. The secondary 
outcome was to evaluate risk factors for PPB in patients with 
liver cirrhosis. The risk factors for PPB were analyzed ac-
cording to patient factors and polyp factors. The patient’s fac-
tors included age, gender, body mass index, underlying dis-
ease, number of polypectomies, and bowel preparation. The 
polyp factors were size, location, morphology, and histology. 
In sub-analysis, risk factors of PPB were evaluated in pa-
tients with liver cirrhosis according to Child-Pugh class. Sta-
tistical analysis was performed using χ2-test, Fisher’s exact 
test, Student’s t-test, and logistic regression analysis. Hazard 
ratios (HRs) and 95% confidence intervals (CIs) were calcu-
lated to estimate the effect of variables. All tests of signifi-
cance were two-tailed, and p values less than 0.05 were 
deemed statistically significant. All statistical analyses were 
performed using the Statistical Package for the Social Sci-
ences (SPSS), version 18.0 (SPSS Inc., Chicago, IL, USA).
 
RESULTS
 
Demographics
Baseline characteristics of the patients are summarized in Ta-
ble 1. The mean number of polypectomies was 2.4 in the liv-
er cirrhosis group and 2.2 in the control group. The insertion 
time tended to increase in the liver cirrhosis group compared 
with the control group (9.7 min vs. 7.7 min, respectively; 
p=0.063). The withdrawal time was not different between the 
inal pain, diarrhea, constipation, hematochezia or meleana. 
The procedure type, such as snare polypectomy or endo-
scopic mucosal resection (EMR), was chosen according to 
the patient’s condition and polyp characteristics. High-fre-
quency electrocautery with blended current was used. No 
case in the present study was treated by cold polypectomy. 
Antiplatelet therapy, such as aspirin or clopidogrel, was dis-
continued at least 3--7 days before the procedures. Immedi-
ate and delayed bleedings were controlled with hemo-clip-
ping or electrocoagulation.
This study was performed in accordance with the ethical 
guidelines of the 1975 Declaration of Helsinki. Written in-
formed consent was obtained from each participant or re-
sponsible family member after possible complications of 
colonic polypectomy had been fully explained. This study 
was approved by the independent Institutional Review 
Board of Severance Hospital.
Definition of IPPB and DPPB
PPB was divided into IPPB and DPPB. IPPB was defined 
as bleeding observed immediately after polypectomy and 
required hemostatic procedures because the bleeding con-
tinued for over 60 s. DPPB was defined as bleeding that oc-
curred at the polypectomy site within 30 days of the proce-
dure and requiring hospitalization or treatment. 
Statistics
The primary outcome was to compare the risk of PPB in 
Table 1. The Clinical Characteristics of Patients with Liver Cirrhosis and without (n=437)
Univariate analysis
Liver cirrhosis (n=89) Control (n=348) p value
Age (yrs) 60.2±8.0 60.5±9.2 0.743 
Male, n (%) 72 (80.9) 288 (82.8) 0.681
Body mass index (mean±SD) 23.8±2.7 23.9±3.0 0.767 
Cardiovascular disease, n (%) 25 (28.1) 103 (29.6) 0.780 
Diabetes mellitus, n (%) 2 (2.2)   4 (1.1) 0.354 
Chronic renal disease, n (%) 1 (1.1)   5 (1.4) >0.999
Abdominal operation history, n (%) 19 (21.3)   53 (15.2) 0.165 
Antiplatelet agents, n (%) 22 (24.7)   74 (21.3) 0.482 
Number of polypectomy (mean±SD)   2.4±2.2   2.2±1.7 0.475 
Adequate bowel preparation, n (%) 82 (82.1) 328 (94.3) 0.459 
Procedure time, n (%)
    Insertion time   9.7±9.3   7.7±5.9 0.063 
    Total procedure time   26.6±17.6   25.7±14.3 0.661 
IPPB, n (%) 11 (12.4) 29 (8.3) 0.240 
DPPB, n (%) 2 (2.2)   1 (0.3) 0.112 
IPPB, immediate post-polypectomy bleeding; DPPB, delayed post-polypectomy bleeding.
Values are expressed as mean with standard deviation (SD) or no (%). 
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and the presence of varices were not significant risk factors 
for IPPB. 
Risk factors for IPPB were analyzed according to polyp-
related factors (Table 4). IPPB occurred in 50 (4.8%) of 
1045 polyps. Polyps with IPPB were larger than polyps 
without IPPB (11.9±9.4 mm vs. 6.7±3.7 mm, respectively; 
p<0.001). Polyps larger than 10 mm were significantly as-
sociated with IPPB compared with those less than 10 mm 
(p<0.001). Pedunculated polyps were significantly associat-
ed with IPPB compared with nonpedunculated polyps (p= 
0.002). Neoplastic polyp was a significant risk factor for 
IPPB compared with non-neoplastic polyp (p=0.016). Re-
garding IPPB of neoplastic colon polyps, 38 polyps were 
low-grade tubular adenomas, 3 were high-grade tubular ad-
enomas, 1 was a low-grade tubulovillous adenoma and 3 
were high-grade tubulovillous adenomas. The polyp loca-
tion was not associated with IPPB (p=0.09). In patients 
with liver cirrhosis, univariate analysis showed that polyps 
greater than or equal to 10 mm, proximal colon location, 
and EMR were significant risk factors for IPPB (Table 5).
Multivariate analysis for IPPB including patient factors 
and polyp factors are shown in Table 6. The multivariate 
analysis revealed that liver cirrhosis with Child-Pugh class 
B or C (HR, 3.5; 95% CI: 1.9--6.3; p<0.001), polyp size 
≥10 mm (HR, 3.6; 95% CI: 1.1--12.1; p<0.032) and pedun-
culated polyp (HR, 2.4; 95% CI: 1.1--5.4; p= 0.022) were 
significant risk factors for IPPB (Table 6). 
DISCUSSION
The current study revealed that liver cirrhosis itself is not a 
two groups. Other clinical characteristics including age, gen-
der, BMI, underlying disease (such as cardiovascular disease, 
diabetes, and chronic renal disease), history of abdominal op-
eration, and antiplatelet use were not statistically different be-
tween the two groups. Among 89 patients with liver cirrho-
sis, 75 (84.3%) were Child-Pugh class A, 10 (11.2%) were 
Child-Pugh class B and 4 (4.5%) were Child-Pugh class C. 
The cause of liver cirrhosis included 69 patients with hepati-
tis B virus infection, 6 with hepatitis C virus infection, 7 with 
alcohol abuse and 7 with miscellaneous reasons. 
In the liver cirrhosis group, 11 (12.4%) and 2 patients 
(2.2%) developed IPPB and DPPB, respectively. In the con-
trol group, 29 patients (8.3%) and 1 patient (0.3%) developed 
IPPB and DPPB, respectively. The incidences of IPPB and 
DPPB were not statistically different between the two groups.
Risk factors for IPPB
The risk factors for IPPB were analyzed according to the 
patients’ factors (Table 2). Univariate analysis showed that 
underlying disease (such as cardiovascular disease, diabetes 
mellitus and chronic renal disease), antiplatelet use, bowel 
preparation, and the number of polypectomies were not sig-
nificant risk factors for IPPB. Liver cirrhosis itself was not 
a risk factor for IPPB (p=0.240).
Subgroup analysis of risk factors for IPPB was performed 
in patients with liver cirrhosis (Table 3). Univariate analysis 
showed that Child-Pugh class B and C were significant risk 
factors for IPPB compared with Child-Pugh class A (p= 
0.013). Other factors, including the hemoglobin level, total 
bilirubin level, albumin level, alanine aminotransferase lev-
el, platelet count and prothrombin time, were not signifi-
cantly associated with IPPB. The etiology of liver cirrhosis 
Table 2. The Risk Factors of Patient for Immediate Post-Polypectomy Bleeding (n=437)
Univariate analysis
No bleeding (n=397) IPPB (n=40) p value
Age (yrs) 60.5±9.0 60.4±8.8 0.974 
Male, n (%) 329 (82.9)    31 (77.5) 0.395 
Body mass index (mean±SD) 23.9±2.9 23.7±2.6 0.701 
Cardiovascular disease, n (%) 113 (28.5)    15 (37.5) 0.231 
Diabetes mellitus, n (%)   6 (1.5) 0 (0) >0.999
Chronic renal disease, n (%)   4 (1.0)    2 (5.0) 0.097 
Abdominal operation history, n (%)   67 (16.9)      5 (12.5) 0.477 
Antiplatelet agents, n (%)   86 (21.7)    10 (25.0) 0.627 
Number of polypectomy (mean±SD) 1.34±0.4 1.35±0.4 0.900 
Adequate bowel preparation, n (%) 371 (93.5)    39 (97.5) 0.495 
Liver cirrhosis, n (%)   78 (19.6)    11 (27.5) 0.240 
IPPB, immediate post-polypectomy bleeding. 
Values are expressed as mean with standard deviation (SD) or no (%).
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Table 3. Patients Related Clinical Characteristics LC Patients According to the Occurrence of Immediate Post-Polypectomy 
Bleeding (n=89)
No bleeding (n=78) IPPB (n=11) p value
Age (yrs) 60.3±7.9 59.5±9.2 0.771 
Male, n (%) 14 (17.9) 3 (27.3) 0.433 
Body mass index (kg/m2) 23.6±2.7 24.9±2.1 0.203 
Hemoglobin (g/dL) 13.7±2.0 13.2±2.0 0.444 
Serum total bilirubin (mg/d)   1.1±1.0   1.0±0.6 0.803 
Serum albumin (g/dL)   4.1±0.5   4.0±0.7 0.588 
Cr (mg/dL)   0.9±0.2   1.9±3.2 0.347 
Serum ALT (IU/L)   37.8±44.8   46.1±60.7 0.584 
Platelet count (×103/L) 133.2±52.0 146.7±76.2 0.457 
Prothrombin time (INR)   1.0±0.1   1.0±0.1 0.781 
Etiology of LC, n (%) 0.085 
    Viral 67 (85.9) 7 (63.6)
    Non-viral 11 (14.1) 4 (36.4)
HCC present, n (%) 20 (25.6) 2 (18.2) 0.725 
Varices present, n (%) 16 (34.0) 2 (22.2) 0.703 
Child-Pugh class, n (%) 0.013 
    A 69 (88.5) 6 (54.5)
    B and C   9 (11.5) 5 (45.5)
Other underlying disease
    Cardiovascular disease, n (%) 20 (25.6) 5 (45.5) 0.280 
    Abdominal operation history, n (%) 15 (19.2) 4 (36.4) 0.239 
    Antiplatelet agents, n (%) 20 (25.6) 3 (27.3) >0.999
Number of polypectomy per subject   2.2±1.9   3.2±3.4 0.384 
Intubation time (min)   9.4±8.1   11.9±15.8 0.611 
Adequate bowel preparation, n (%) 71 (91.0) 11 (100.0)
LC, liver cirrhosis; IPPB, immediate post-polypectomy bleeding; ALT, alanine aminotransferase; INR, international normalized ratio; HCC, hepatocellular 
carcinoma.
Values are expressed as mean with standard deviation (SD) or no (%).
Table 4. The Polyp Related Risk Factor for Immediate Post-Polypectomy Bleeding (n=1045)
Univariate analysis
No bleeding IPPB p value
Polyp numbers 995 50
Size (mm) <0.001
    <10, n (%) 838 (84.2) 26 (52.0)
    ≥10, n (%) 157 (15.8) 24 (48.0)
Location of polyp, n (%)  0.090 
    Distal 520 (52.3) 20 (40.0)
    Proximal 475 (47.7) 30 (60.0)
Gross morphology, n (%)  0.002 
    Nonpedunculated 906 (91.1) 38 (76.0)
    Pedunculated 89 (8.9) 12 (24.0)
Histology, n (%)  0.016 
    Non-neoplastic colorectal polyp 264 (26.5)   5 (10.0)
    Neoplastic colorectal polyp 731 (73.5) 45 (90.0)
Method of polypectomy, n (%) 0.025
    Snare polypectomy 863 (86.7) 28 (56.0)
    EMR 132 (13.3) 22 (44.0)
IPPB, immediate post-polypectomy bleeding; Distal, from splenic flexure to rectum; Proximal, from cecum to transverse colon; Neoplastic colorectal polyp, 
adenocarcinoma, tubular, villous, tubulovillous, and serrated adenoma; Non-neoplastic colorectal polyp, inflammatory polyp and hyperplastic polyp; EMR, 
endoscopic mucosal resection.
Sangheun Lee, et al.
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 20141286
ple elevation of liver enzymes as well as liver cirrhosis. 
Furthermore, a recent single center study with a small sam-
ple size reported IPPB in 3.03% of patients with early liver 
cirrhosis, and the authors concluded that early liver cirrhosis 
was not a significant risk factor for immediate bleeding after 
colonoscopic polypectomy.25 However, the study failed to 
show the risk of IPPB in patients with decompensated liver 
cirrhosis because only one patient with Child-Pugh class C 
liver cirrhosis was included. In our present study, we found 
that the compensated liver cirrhosis is not a risk factor for 
IPPB, however, the decompensated liver cirrhosis is a sig-
nificant risk factor for IPPB. 
The present study revealed that each laboratory result, 
such as the platelet count or prothrombin time, could not 
predict the risk for IPPB in patients with liver cirrhosis. Ad-
ditionally, the severity of portal hypertension was not asso-
ciated with the risk of IPPB. Because liver cirrhosis itself 
has bleeding tendency, it would be interesting to know 
whether antiplatelet would increase the risk of bleeding af-
risk factor for IPPB. However, patients with decompensat-
ed liver cirrhosis had a high risk for IPPB after colonoscop-
ic polypectomy compared to those with normal liver func-
tion. Thus, endoscopists should be cautious to perform 
colonoscopic polypectomy in patients with liver cirrhosis 
of Child-Pugh class B or C. 
A previous study has reported that 31% of patients with 
less than 75000 platelets per mm3 displayed bleeding in inva-
sive procedures.22 Because splenomegaly is related with 
thrombocytopenia,23 invasive procedure can lead to the com-
plications in liver cirrhosis. Additionally, patients with liver 
cirrhosis have coagulopathy originating from the disease it-
self. The disruption of these opposing coagulation path-
ways can change hemostatic activity for individual patients 
with cirrhosis.24 Thus, colonoscopists have been reluctant to 
perform these invasive procedures that can cause bleeding. 
However, a previous prospective multicenter study showed 
that chronic liver disease was not a significant risk factor 
for IPPB.12 In this study, chronic liver disease included sim-
Table 5. The Polyp Related Characteristics of LC Patients According to the Occurrence of Immediate Bleeding (n=218)
No bleeding (n=201) IPPB (n=17) p value
Size, mm 0.047
    <10, n (%) 170 (84.6) 11 (64.7)
    ≥10, n (%)   31 (15.4)   6 (35.3)
Location of polyp, n (%) 0.019
    Distal 107 (53.2)   4 (23.5)
    Proximal   94 (46.8) 13 (76.5)
Gross morphology, n (%) 0.480 
    Nonpedunculated 175 (87.1) 14 (82.4)
    Pedunculated   26 (12.9)   3 (17.6)
Histology, n (%) 0.129
    Non-neoplastic colorectal polyp   47 (23.4) 1 (5.9)
    Neoplastic colorectal polyp 154 (76.6) 16 (94.1)
Method of polypectomy, n (%) 0.031
    Snare polypectomy 189 (94.0) 12 (70.6)
    EMR 12 (6.0)   5 (29.4)
IPPB, immediate post-polypectomy bleeding; Distal, from splenic flexure to rectum; Proximal, from cecum to transverse colon; Neoplastic colorectal polyp, 
adenocarcinoma, tubular, villous, tubulovillous, and serrated adenoma; Non-neoplastic colorectal polyp, inflammatory polyp and hyperplastic polyp; EMR, 
endoscopic mucosal resection; LC, liver cirrhosis.
Table 6. Multivariate Analysis of Risk Factors for Immediate Post-Polypectomy Bleeding
Variables
IPPB
HR (95% CI) p value
Child-Pugh class B and C (vs. A) 3.5 (1.9--6.3) <0.001
≥10 mm of polyp size (vs. <10 mm)   3.6 (1.1--12.1)  0.032 
Pedunculated polyp (vs. nonpeduculated) 2.4 (1.1--5.4)  0.022 
Neoplastic polyp (vs. non-neoplastic polyp) 1.1 (0.9--1.2)  0.065 
EMR (vs. snare polypectomy) 1.5 (0.3--6.9)  0.546
HR, hazard ratio; CI, confidential interval; Neoplastic colorectal polyp, adenocarcinoma, tubular, villous, tubulovillous, and serrated adenoma; Non-neoplas-
tic colorectal polyp, inflammatory polyp and hyperplastic polyp; EMR, endoscopic mucosal resection; IPPB, immediate post-polypectomy bleeding.
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In conclusion, liver cirrhosis itself is not an adverse fac-
tor for colonoscopic polypectomy. However, cirrhotic pa-
tients with Child Pugh class B or C have a high risk of 
IPPB. Thus, endoscopists should be cautious about per-
forming colonoscopic polypectomy in those patients.
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